Onconova Therapeutics Inc (ONTX):企業の財務・戦略的SWOT分析

◆英語タイトル:Onconova Therapeutics Inc (ONTX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH137574FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Onconova Therapeutics Inc (ONTX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Onconova Therapeutics Inc (Onconova) is a biopharmaceutical company that discovers and develops small molecule drug candidates for the treatment of cancer. The company’s drug candidates include rigosertib, briciclib and recilisib. It develops drug candidates that target cancer and protect healthy cells based on its proprietary chemistry platform and cell-based differential screening. Onconova’s rigosertib is targeted at meeting medical needs of patients with myelodysplastic syndromes. The company’s recilisib is used to treat the effects of acute radiation syndromes such as cytopenia. It partners with biopharmaceutical companies and medical organizations in the US. The company operates through its offices in Newtown and Pennington, the US. Onconova is headquartered in Newtown, Pennsylvania, the US.

Onconova Therapeutics Inc Key Recent Developments

Mar 29,2021: Onconova to Present at the Spring 2021 Oncology Investor Conference
Mar 04,2021: Onconova Therapeutics to Provide Corporate Update and Full Year 2020 Financial Results
Feb 16,2021: Onconova Therapeutics to Present Corporate Update at the 2021 BIO CEO & Investor Digital Conference
Feb 16,2021: Onconova Therapeutics, Inc. Announces Closing of $28.75 Million Public Offering of Common Stock Including Full Exercise of the Over-Allotment Option
Feb 10,2021: Onconova Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Onconova Therapeutics Inc – Key Facts
Onconova Therapeutics Inc – Key Employees
Onconova Therapeutics Inc – Key Employee Biographies
Onconova Therapeutics Inc – Major Products and Services
Onconova Therapeutics Inc – History
Onconova Therapeutics Inc – Company Statement
Onconova Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Onconova Therapeutics Inc – Business Description
R&D Overview
Onconova Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Onconova Therapeutics Inc – Strengths
Onconova Therapeutics Inc – Weaknesses
Onconova Therapeutics Inc – Opportunities
Onconova Therapeutics Inc – Threats
Onconova Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Onconova Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 29, 2021: Onconova to Present at the Spring 2021 Oncology Investor Conference
Mar 04, 2021: Onconova Therapeutics to Provide Corporate Update and Full Year 2020 Financial Results
Feb 16, 2021: Onconova Therapeutics to Present Corporate Update at the 2021 BIO CEO & Investor Digital Conference
Jan 14, 2021: Onconova Therapeutics appoints Richard C. Woodman as Chief Medical Officer
Nov 12, 2020: Onconova Therapeutics reports third quarter 2020 financial results and provides business update
Aug 31, 2020: Onconova Therapeutics announces Election of James J. Marino, JD, MBA as Chairman of the Board of Directors
Aug 27, 2020: Onconova Therapeutics : Departure of Directors
Aug 12, 2020: Onconova Therapeutics highlights corporate progress and reports second quarter 2020 financial results
Jul 09, 2020: Onconova Therapeutics announces appointment of board of directors
Apr 27, 2020: Onconova Therapeutics strengthens Board of Directors with nomination of life sciences industry veteran
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Onconova Therapeutics Inc, Key Facts
Onconova Therapeutics Inc, Key Employees
Onconova Therapeutics Inc, Key Employee Biographies
Onconova Therapeutics Inc, Major Products and Services
Onconova Therapeutics Inc, History
Onconova Therapeutics Inc, Subsidiaries
Onconova Therapeutics Inc, Key Competitors
Onconova Therapeutics Inc, Ratios based on current share price
Onconova Therapeutics Inc, Annual Ratios
Onconova Therapeutics Inc, Annual Ratios (Cont...1)
Onconova Therapeutics Inc, Interim Ratios
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Onconova Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Onconova Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Onconova Therapeutics Inc (ONTX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UK Mail Group Plc (UKM):企業の財務・戦略的SWOT分析
    UK Mail Group Plc (UKM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • M. A. Mortenson Co:戦略・SWOT・企業財務分析
    M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • BASF SE (BAS):石油・ガス:M&Aディール及び事業提携情報
    Summary BASF SE (BASF) is a chemical company, which carries out the research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additive …
  • Nippon Paint Holdings Co Ltd (4612):企業の財務・戦略的SWOT分析
    Nippon Paint Holdings Co Ltd (4612) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ludwig Institute For Cancer Research Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Ludwig Institute for Cancer Research Ltd (LICR) is a non-profit organization that conducts cancer research and clinical trial programs. The organization carries out research in the areas of clinical trials, genomics, cell biology, immunology, neuroscience, signaling, therapeutics, stem cells …
  • China Resources Enterprise Ltd:企業の戦略的SWOT分析
    China Resources Enterprise Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Nuance Communications, Inc.:企業の戦略・SWOT・財務情報
    Nuance Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nuance Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Accord Financial Corp. (ACD):企業の財務・戦略的SWOT分析
    Accord Financial Corp. (ACD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Netflix Inc.:企業の戦略・SWOT・財務分析
    Netflix Inc. - Strategy, SWOT and Corporate Finance Report Summary Netflix Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Thetis Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Thetis Pharmaceuticals LLC (Thetis Pharma) is a drug manufacturing company that offers novel immuno-resolving therapies. The company develops and manufactures drugs for type two diabetes and chronic conditions. Its pipeline products include TP252, TP6211, TP113, and TP 101. Thetis Pharma’s T …
  • RPM International Inc:戦略・SWOT・企業財務分析
    RPM International Inc - Strategy, SWOT and Corporate Finance Report Summary RPM International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hosken Consolidated Investments Ltd (HCI):企業の財務・戦略的SWOT分析
    Hosken Consolidated Investments Ltd (HCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • KineMed Inc-製薬・医療分野:企業M&A・提携分析
    Summary KineMed Inc (KineMed) is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs …
  • Esperite NV (ESP):企業の財務・戦略的SWOT分析
    Esperite NV (ESP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sc Arcada Con Srl:企業の戦略的SWOT分析
    Sc Arcada Con Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Eiken Chemical Co Ltd (4549):企業の製品パイプライン分析2018
    Summary Eiken Chemical Co Ltd (Eiken Chemical), a subsidiary of Hitachi High-Technologies Corp is a medical equipment provider that offers molecular genetic products and medical devices. The company manufactures and markets clinical diagnostics and equipment, among others. It also provides fecal imm …
  • Philippine Long Distance Telephone Co (TEL):企業の財務・戦略的SWOT分析
    Philippine Long Distance Telephone Co (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Taiflex Scientific Co Ltd (8039):企業の財務・戦略的SWOT分析
    Taiflex Scientific Co Ltd (8039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hualan Biological Engineering Inc (002007):企業の財務・戦略的SWOT分析
    Summary Hualan Biological Engineering Inc (Hualan Biological) is a biopharmaceutical company that develops vaccines. The company conducts research, develops and produces plasma, vaccines and gene products. Its plasma products include surgical lyophilized fibrin sealant, human coagulation factor VIII …
  • Finastra Group Holdings Limited:企業のM&A・事業提携・投資動向
    Finastra Group Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Finastra Group Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆